Description
PHARMACEUTICALS FOR DIRECT PATIENT CARE.
First action · last action
2016-03-03 · 2016-03-03
Transactions
1
First transaction's obligation
$8,061
Base + all options value (sum of deltas)
$8,061
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D30268
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-03-03+$8,061= $8,061
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-03-03 | +$8,061 | $8,061 | PHARMACEUTICALS FOR DIRECT PATIENT CARE. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NG61ZA8TADW3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0394 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $891,651 | FY2026 |
| 36C26226F0314 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $823,062 | FY2026 |
| 36C24526N0724 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $34,874 | FY2026 |
| 36C24526N0622 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $34,874 | FY2026 |
| 36C25026N0416 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $617,297 | FY2026 |
| 36C24526N0566 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $34,874 | FY2026 |
Other recipients under 6515 from 688-WASHINGTON DC (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24516P1699 | PARAGON 28, INC. | 688-WASHINGTON DC | $4,685 | FY2016 |
| VA24516P0494 | HOWMEDICA OSTEONICS CORP | 688-WASHINGTON DC | $43,491 | FY2016 |
| VA24516P0443 | DESTINY SURGICAL PRODUCTS LLC | 688-WASHINGTON DC | $5,387 | FY2016 |
| VA24516P0458 | DEPUY SYNTHES SALES INC | 688-WASHINGTON DC | $9,334 | FY2016 |
| VA24516P0338 | DYNATRONICS CORP | 688-WASHINGTON DC | $1,905 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24516F0439_3600_V797D30268_3600 · retrieved 2026-09-26.